Literature DB >> 16032672

Brain gamma-aminobutyric acid measurement by proton double-quantum filtering with selective J rewinding.

Changho Choi1, Nicholas J Coupland, Christopher C Hanstock, Catherine J Ogilvie, Andrea C M Higgins, Dan Gheorghiu, Peter S Allen.   

Abstract

An optimized single-shot proton double-quantum (DQ) filter for the quantification of gamma-aminobutyric acid (GABA) levels in human brain is reported. It is demonstrated that creation of DQ coherences following dual-resonance-selective refocusing gives a theoretical editing efficiency of 50% for the detection of the GABA resonance at 3.01 ppm. The sequence times are optimized with both numerical and experimental analyses of the editing performance, giving an experimental editing efficiency of 42%. It is acknowledged that homocarnosine is partially coedited, leading to a 20% contribution to the edited signal; however, macromolecule contamination is negligible in vivo under these experimental conditions. The GABA concentration in human prefrontal cortex is estimated to be 0.8 +/- 0.1 micromol/g (mean +/- SD, n = 6), with reference to the internal standard creatine at 9 micromol/g. 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16032672     DOI: 10.1002/mrm.20563

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  12 in total

Review 1.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

2.  GAVA: spectral simulation for in vivo MRS applications.

Authors:  Brian J Soher; Karl Young; Aaron Bernstein; Zakaria Aygula; Andrew A Maudsley
Journal:  J Magn Reson       Date:  2007-01-12       Impact factor: 2.229

Review 3.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

4.  Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T.

Authors:  Jiani Hu; Shaolin Yang; Yang Xuan; Quan Jiang; Yihong Yang; E Mark Haacke
Journal:  J Magn Reson       Date:  2006-12-22       Impact factor: 2.229

5.  Distinction of the GABA 2.29 ppm resonance using triple refocusing at 3 T in vivo.

Authors:  Vivek Tiwari; Zhongxu An; Yiming Wang; Changho Choi
Journal:  Magn Reson Med       Date:  2018-02-14       Impact factor: 4.668

Review 6.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

7.  Anterior cingulate and cerebellar GABA and Glu correlations measured by ¹H J-difference spectroscopy.

Authors:  Kevin W Waddell; Parham Zanjanipour; Subechhya Pradhan; Lei Xu; Edward B Welch; James M Joers; Peter R Martin; Malcolm J Avison; John C Gore
Journal:  Magn Reson Imaging       Date:  2010-09-29       Impact factor: 2.546

8.  Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

Authors:  Chris C Streeter; John Hennen; Yong Ke; J Eric Jensen; Ofra Sarid-Segal; Leanne E Nassar; Clifford Knapp; Angela A Meyer; Tae Kwak; Perry F Renshaw; Domenic A Ciraulo
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

9.  Measurement of regional variation of GABA in the human brain by optimized point-resolved spectroscopy at 7 T in vivo.

Authors:  Sandeep K Ganji; Zhongxu An; Abhishek Banerjee; Akshay Madan; Keith M Hulsey; Changho Choi
Journal:  NMR Biomed       Date:  2014-08-04       Impact factor: 4.044

10.  Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia.

Authors:  A D Stan; S Ghose; C Zhao; K Hulsey; P Mihalakos; M Yanagi; S U Morris; J J Bartko; C Choi; C A Tamminga
Journal:  Mol Psychiatry       Date:  2014-06-10       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.